The Lytic Activity of Bacteriophage ZCSE9 against Salmonella enterica and Its Synergistic Effects with Kanamycin
Viruses · 2023
DOI: 10.3390/v15040912 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Abdallah S Abdelsattar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Microbiology and Phage Therapy, Zewail City of Science and Technology, Giza 12578, Egypt. Hauptthemen laut MEDLINE: Bacteriophages, Salmonella enterica, Salmonella Infections, Salmonella Phages. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Egyptian Sciences and Technology Development Fund (STDF).
Abstract (Originalsprache)
Salmonella, the causative agent of several diseases in humans and animals, including salmonellosis, septicemia, typhoid fever, and fowl typhoid, poses a serious threat to global public health and food safety. Globally, reports of therapeutic failures are increasing because of the increase in bacterial antibiotic resistance. Thus, this work highlights the combined phage–antibiotic therapy as a promising approach to combating bacterial resistance. In this manner, the phage ZCSE9 was isolated, and the morphology, host infectivity, killing curve, combination with kanamycin, and genome analysis of this phage were all examined. Morphologically, phage ZCSE9 is a siphovirus with a relatively broad host range. In addition, the phage can tolerate high temperatures until 80 °C with one log reduction and a basic environment (pH 11) without a significant decline. Furthermore, the phage prevents bacterial growth in the planktonic state, according to the results of the time-killing curve. Moreover, using the phage at MOI 0.1 with kanamycin against five different Salmonella serotypes reduces the required antibiotics to inhibit the growth of the bacteria. Comparative genomics and phylogenetic analysis suggested that phage ZCSE9, along with its close relatives Salmonella phages vB_SenS_AG11 and wksl3, belongs to the genus Jerseyvirus. In conclusion, phage ZCSE9 and kanamycin form a robust heterologous antibacterial combination that enhances the effectiveness of a phage-only approach for combating Salmonella.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Microbiology and Phage Therapy, Zewail City of Science and Technology, Giza 12578, Egypt.
- Microbiology and Immunology Department, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza 11787, Egypt.
- Faculty of Environmental Agricultural Sciences, Arish University, Arish 45511, Egypt.
ORCID-Profile: Abdallah S Abdelsattar, Mohamed Atef Eita, Zainab K Hammouda, Shrouk Mohamed Gouda, Anan Safwat, Ayman El-Shibiny
Förderung
- Egyptian Sciences and Technology Development Fund (STDF)
Zitieren
APA
Abdelsattar, A. S., Eita, M. A., Hammouda, Z. K., Gouda, S. M., Hakim, T. A., Yakoup, A. Y., Safwat, A., & El-Shibiny, A. (2023). The Lytic Activity of Bacteriophage ZCSE9 against Salmonella enterica and Its Synergistic Effects with Kanamycin. Viruses. https://doi.org/10.3390/v15040912
Vancouver
Abdelsattar AS, Eita MA, Hammouda ZK, Gouda SM, Hakim TA, Yakoup AY, et al. The Lytic Activity of Bacteriophage ZCSE9 against Salmonella enterica and Its Synergistic Effects with Kanamycin. Viruses. 2023. doi:10.3390/v15040912
BibTeX
@article{Abdelsattar2023,
author = {Abdelsattar, Abdallah S and Eita, Mohamed Atef and Hammouda, Zainab K and Gouda, Shrouk Mohamed and Hakim, Toka A and Yakoup, Aghapy Yermans and Safwat, Anan and El-Shibiny, Ayman},
title = {The Lytic Activity of Bacteriophage ZCSE9 against Salmonella enterica and Its Synergistic Effects with Kanamycin},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040912}
}
EUVIMED